OpenURL Connection Search

Select item for more details and to access through your institution.

PFKFB2 is a favorable prognostic biomarker for colorectal cancer by suppressing metastasis and tumor glycolysis.
Published in:
Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 12, p. 10737, doi. 10.1007/s00432-023-04946-1
By:
- Liu, Furong;
- Wei, Xiaoli;
- Chen, Zhanhong;
- Chen, Yanxing;
- Hu, Peishan;
- Jin, Ying
Publication type:
Article
Preoperative prediction of pathologic grade of HCC on gadobenate dimeglumine-enhanced dynamic MRI.
Published in:
European Radiology, 2021, v. 31, n. 10, p. 7584, doi. 10.1007/s00330-021-07891-0
By:
- Rong, Dailin;
- Liu, Weimin;
- Kuang, Sichi;
- Xie, Sidong;
- Chen, Zhanhong;
- Chen, Feifei;
- Xie, Qianwei;
- Luo, Qiuxia;
- He, Bingjun;
- Zhang, Yao;
- Deng, Ying;
- Yang, Hao;
- Chen, Simin;
- Wang, Jin
Publication type:
Article
Study on Dormant and Germination Characteristics of Chinese Olive (Canarium album) Seeds.
Published in:
Horticulturae, 2024, v. 10, n. 4, p. 362, doi. 10.3390/horticulturae10040362
By:
- Xie, Qian;
- Ye, Qinghua;
- Liu, Ting;
- Chen, Zhanhong;
- Chen, Qingxi
Publication type:
Article
Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA genomic profiling.
Published in:
Molecular Genetics & Genomic Medicine, 2020, v. 8, n. 2, p. N.PAG, doi. 10.1002/mgg3.1079
By:
- Chen, Zhanhong;
- Sun, Tian;
- Yang, Ziyan;
- Zheng, Yabing;
- Yu, Ruoying;
- Wu, Xue;
- Yan, Junrong;
- Shao, Yang W;
- Shao, Xiying;
- Cao, Wenming;
- Wang, Xiaojia
Publication type:
Article
Multi-organ Immune-Related Adverse Event Is a Risk Factor of Immune Checkpoint Inhibitor Associated Myocarditis in Cancer Patients: A Multi-center Study.
Published in:
Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.879900
By:
- Xiaohong Xie;
- Liqiang Wang;
- Yingqing Li;
- Yan Xu;
- Jianhui Wu;
- Xinqing Lin;
- Wen Lin;
- Qicong Mai;
- Zhanhong Chen;
- Jiexia Zhang;
- Zhanhong Xie;
- Yinyin Qin;
- Ming Liu;
- Mingjun Lu;
- Bihui Luo;
- Chengzhi Zhou
Publication type:
Article
Pyrotinib plus docetaxel as first-line treatment for HER2-positive metastatic breast cancer: the PANDORA phase II trial.
Published in:
Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-44140-y
By:
- Zheng, Yabing;
- Cao, Wen-Ming;
- Shao, Xiying;
- Shi, Yanxia;
- Cai, Li;
- Chen, Wenyan;
- Liu, Jian;
- Shen, Peng;
- Chen, Yiding;
- Wang, Xian;
- Li, Huiping;
- Li, Man;
- Chen, Zhanhong;
- Wang, Xiaojia
Publication type:
Article
The CYP19 RS4646 Polymorphism IS Related to the Prognosis of Stage I–II and Operable Stage III Breast Cancer.
Published in:
PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0121535
By:
- Shao, Xiying;
- Guo, Yong;
- Xu, Xiaohong;
- Zheng, Yabing;
- Wang, Jiwen;
- Chen, Zhanhong;
- Huang, Jian;
- Huang, Ping;
- Cai, Jufen;
- Wang, Xiaojia
Publication type:
Article
MicroRNA and LncRNA Expression Profiles in Human Estrogen Receptor Positive Breast Cancer.
Published in:
Clinical Laboratory, 2019, v. 65, n. 1/2, p. 7, doi. 10.7754/Clin.Lab.2018.180340
By:
- Xiying Shao;
- Ping Huang;
- Lei Shi;
- Lei Lei;
- Wenming Cao;
- Zhanhong Chen;
- Xiaojia Wang;
- Yabing Zheng
Publication type:
Article
Everolimus‐containing therapy vs conventional therapy in the treatment of refractory breast cancer patients with PI3K/AKT/mTOR mutations: A retrospective study.
Published in:
Cancer Medicine, 2019, v. 8, n. 12, p. 5544, doi. 10.1002/cam4.2460
By:
- Chen, Zhanhong;
- Zheng, Yabing;
- Cao, Wenming;
- Zhang, Yuzi;
- Zhao, Zhengyi;
- Wang, Guoqiang;
- Zhao, Jing;
- Cai, Shangli;
- Shao, Xiying;
- Huang, Jian;
- Ye, Weiwu;
- Huang, Yuan;
- Li, Wei;
- Huang, Xiang;
- Wu, Hao;
- Wang, Xiaojia;
- Yin, Yongmei
Publication type:
Article
Complete Response With Cetuximab-Based Treatment of Metastatic Colorectal Cancers: Two Case Reports and Literature Review.
Published in:
Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.798515
By:
- Wei, Li;
- Lin, Zexiao;
- Xie, Sidong;
- Ruan, Danyun;
- Jiang, Wen;
- Cui, Yueli;
- Liu, Sisi;
- Wang, Tiantian;
- Chen, Zhanhong;
- Lin, Qu
Publication type:
Article
Role of estrogen receptor in breast cancer cell gene expression.
Published in:
Molecular Medicine Reports, 2016, v. 13, n. 5, p. 4046, doi. 10.3892/mmr.2016.5018
By:
- YABING ZHENG;
- XIYING SHAO;
- YUAN HUANG;
- LEI SHI;
- BO CHEN;
- XIAOJIA WANG;
- HONGJIAN YANG;
- ZHANHONG CHEN;
- XIPING ZHANG
Publication type:
Article
Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study.
Published in:
PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0155132
By:
- Lei, Lei;
- Yu, Xingfei;
- Chen, Bo;
- Chen, Zhanhong;
- Wang, Xiaojia
Publication type:
Article
Efficacy of Oxaliplatin/5-Fluorouracil/Capecitabine-Cetuximab Combination Therapy and Its Effects on K-Ras Mutations in Advanced Colorectal Cancer.
Published in:
Medical Science Monitor, 2020, v. 26, p. 1, doi. 10.12659/MSM.919031
By:
- Li Wei;
- Jie Chen;
- Jingyun Wen;
- DonghaoWu;
- Xiaokun Ma;
- Zhanhong Chen;
- Jianglong Huang
Publication type:
Article
Image super‐resolution based on conditional generative adversarial network.
Published in:
IET Image Processing (Wiley-Blackwell), 2020, v. 14, n. 13, p. 3006, doi. 10.1049/iet-ipr.2018.5767
By:
- Gao, Hongxia;
- Chen, Zhanhong;
- Huang, Binyang;
- Chen, Jiahe;
- Li, Zhifu
Publication type:
Article
Landscape of potentially targetable receptor tyrosine kinase fusions in diverse cancers by DNA-based profiling.
Published in:
NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00325-0
By:
- Wang, Tiantian;
- Wei, Li;
- Lu, Qiang;
- Shao, Yanmei;
- You, Shuqing;
- Yin, Jiani C.;
- Wang, Sha;
- Shao, Yang;
- Chen, Zhanhong;
- Wang, Zhe
Publication type:
Article
Bioinformatics identification of dysregulated microRNAs in triple negative breast cancer based on microRNA expression profiling.
Published in:
Oncology Letters, 2018, v. 15, n. 3, p. 3017, doi. 10.3892/ol.2017.7707
By:
- ChEN, Junqing;
- ChEN, Zhanhong;
- Huang, Jian;
- ChEN, FENg;
- Ye, Weiwu;
- Ding, Guojun;
- Wang, Xiaojia
Publication type:
Article
Rs1008805 polymorphism of CYP19A1 gene is associated with the efficacy of hormone therapy in stage I-II and operable stage III breast cancer.
Published in:
Oncology Letters, 2017, v. 14, n. 5, p. 6156, doi. 10.3892/ol.2017.6984
By:
- XIYING SHAO;
- LEI LUO;
- YONG GUO;
- XIAOHONG XU;
- DEHOU DENG;
- JIANGUO FENG;
- YUHENG DING;
- HANZHOU MOU;
- PING HUANG;
- LEI SHI;
- YUAN HUANG;
- WEIWU YE;
- CAIJIN LOU;
- ZHANHONG CHEN;
- YABING ZHENG;
- XIAOJIA WANG
Publication type:
Article
Expression of cluster of differentiation 34 and vascular endothelial growth factor in breast cancer, and their prognostic significance.
Published in:
Oncology Letters, 2015, v. 10, n. 2, p. 723, doi. 10.3892/ol.2015.3348
By:
- ZHANHONG CHEN;
- SHENHUA XU;
- WEIZHEN XU;
- JIAN HUANG;
- GU ZHANG;
- LEI LEI;
- XIYING SHAO;
- XIAOJIA WANG
Publication type:
Article
Treatment after Progression on Fulvestrant among Metastatic Breast Cancer Patients in Clinical Practice: a Multicenter, Retrospective Study.
Published in:
Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-37472-z
By:
- Xie, Yizhao;
- Zhao, Yannan;
- Gong, Chengcheng;
- Chen, Zhanhong;
- Zhang, Yinbin;
- Zhao, Yanxia;
- Yuan, Peng;
- Hu, Sainan;
- Li, Yi;
- Hu, Xichun;
- Zhang, Jian;
- Wang, Leiping;
- Wang, Biyun
Publication type:
Article
Real-World First-Line Treatment Patterns and Outcomes in Hormone Receptor-Positive Advanced Breast Cancer Patients: A Multicenter, Retrospective Study in China.
Published in:
Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.829693
By:
- Chen, Zhanhong;
- Ouyang, Quchang;
- Wang, Yongsheng;
- Wang, Junsheng;
- Wang, Haixue;
- Wu, Xiaohong;
- Zhang, Peili;
- Huang, Jian;
- Zheng, Yabing;
- Cao, Wenming;
- Shao, Xiying;
- Xie, Ning;
- Tian, Can;
- Liang, Hao;
- Wang, Cailing;
- Zhang, Ying;
- Ren, Dianquan;
- Wang, Xiaojia
Publication type:
Article
Demethylation of miR‐195 suppresses prostate cancer cell proliferation, migration and invasion.
Published in:
FEBS Open Bio, 2020, v. 10, n. 4, p. 525, doi. 10.1002/2211-5463.12799
By:
- Ma, Xiaokun;
- Zou, Liyuan;
- Chen, Zhanhong;
- Li, Xing;
- Wei, Li;
- Wu, Xiangyuan
Publication type:
Article
Prognostic significance of mammary Paget's disease in Chinese women: a 10 year, population-based, matched cohort study.
Published in:
OncoTargets & Therapy, 2018, v. 11, p. 8319, doi. 10.2147/OTT.S171710
By:
- Zhou, Huanhuan;
- Lu, Kongbeng;
- Zheng, Lei;
- Guo, Liwei;
- Gao, Yun;
- Miao, Xianyuan;
- Chen, Zhanhong;
- Wang, Xiaojia
Publication type:
Article
Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody‐drug conjugates–induced interstitial lung disease/pneumonitis: An expert consensus in China.
Published in:
Cancer (0008543X), 2024, v. 130, p. 3054, doi. 10.1002/cncr.35475
By:
- Xu, Chunwei;
- Chen, Zhanhong;
- Xia, Yuanli;
- Shi, Yanxia;
- Fu, Peifen;
- Chen, Yiding;
- Wang, Xian;
- Zhang, Lili;
- Li, Hengyu;
- Chen, Wenyan;
- Fu, Jianfei;
- Huang, Liming;
- Shu, Jingde;
- Wang, Ouchen;
- Wu, Weizhu;
- Xie, Bojian;
- Wang, Ting;
- Zhang, Weiping;
- Shen, Shurong;
- Li, Qun
Publication type:
Article
Serum biomarker 3144 m/z for prognostic detection in Chinese postmenopausal breast cancer patients.
Published in:
Journal of Cancer Research & Therapeutics, 2015, v. 11, p. C68, doi. 10.4103/0973-1482.163844
By:
- Yun Gao;
- ShenHua Xu;
- Wenming Cao;
- Zhanhong Chen;
- Xiaojia Wang;
- Dehong Zou
Publication type:
Article
MicroRNA-126 Inhibit Viability of Colorectal Cancer Cell by Repressing mTOR Induced Apoptosis and Autophagy [Retraction].
Published in:
2024
By:
- Wei, Li;
- Chen, Zhanhong;
- Cheng, Na;
- Li, Xing;
- Chen, Jie;
- Wu, Donghao;
- Dong, Min;
- Wu, Xiangyuan
Publication type:
Correction Notice
MicroRNA-126 Inhibit Viability of Colorectal Cancer Cell by Repressing mTOR Induced Apoptosis and Autophagy.
Published in:
OncoTargets & Therapy, 2020, v. 13, p. 2459, doi. 10.2147/OTT.S238348
By:
- Wei, Li;
- Chen, Zhanhong;
- Cheng, Na;
- Li, Xing;
- Chen, Jie;
- Wu, Donghao;
- Dong, Min;
- Wu, Xiangyuan
Publication type:
Article
Downregulation of miR-200c-3p contributes to the resistance of breast cancer cells to paclitaxel by targeting SOX2.
Published in:
Oncology Reports, 2018, v. 40, n. 6, p. 3821, doi. 10.3892/or.2018.6735
By:
- Chen, Junqing;
- Tian, Wei;
- He, Haifei;
- Chen, Feng;
- Huang, Jian;
- Wang, Xiaojia;
- Chen, Zhanhong
Publication type:
Article
miR-181b promotes chemoresistance in breast cancer by regulating Bim expression.
Published in:
Oncology Reports, 2016, v. 35, n. 2, p. 683, doi. 10.3892/or.2015.4417
By:
- YABING ZHENG;
- XIAOAI LV;
- XIAOJIA WANG;
- BEI WANG;
- XIYING SHAO;
- YUAN HUANG;
- LEI SHI;
- ZHANHONG CHEN;
- JIAN HUANG;
- PING HUANG
Publication type:
Article

Found: 28